<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Novel Immunolocalization of ␣-Synuclein in Human Muscle of Inclusion-Body Myositis, Regenerating and Necrotic Muscle Fibers, and at Neuromuscular Junctions</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Valerie</forename><surname>Askanas</surname></persName>
						</author>
						<author>
							<persName><roleName>PHD</roleName><forename type="first">W</forename><surname>King Engel</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Renate</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
						</author>
						<author>
							<persName><roleName>MSC</roleName><forename type="first">Janis</forename><surname>Mcferrin</surname></persName>
						</author>
						<author>
							<persName><roleName>BSC</roleName><forename type="first">Aldobrando</forename><surname>Broccolini</surname></persName>
						</author>
						<title level="a" type="main">Novel Immunolocalization of ␣-Synuclein in Human Muscle of Inclusion-Body Myositis, Regenerating and Necrotic Muscle Fibers, and at Neuromuscular Junctions</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">BAE700E8D8CA75746D56EB77C337D623</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>␣-synuclein</term>
					<term>Cultured human muscle</term>
					<term>Inclusion-body myositis</term>
					<term>Necrotic muscle fibers</term>
					<term>Neuromuscular junctions</term>
					<term>Regenerating muscle fibers</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>␣-synuclein (␣-syn) is an important component of neuronal and glial inclusions in brains of patients with several neurodegenerative disorders. Sporadic inclusion-body myositis (s-IBM) is the most common progressive muscle disease of older patients. Its muscle phenotype shows several similarities with Alzheimer disease brain. A distinct feature of s-IBM pathology is specific vacuolar degeneration of muscle fibers characterized by intracellular amyloid inclusions formed by both amyloid-␤ (A␤) and paired-helical filaments composed of phosphorylated tau. We immunostained ␣-syn in muscle biopsies of s-IBM, disease-control, and normal patients. Approximately 60% of A␤-positive vacuolated muscle fibers (VMF) contained well-defined inclusions immunoreactive with antibodies against ␣-syn. In those fibers, ␣-syn co-localized with A␤, both by light microscopy, and ultrastructurally. Paired-helical filaments did not contain ␣-syn immunoreactivity. In all muscle biopsies, ␣-syn was strongly immunoreactive at the postsynaptic region of the neuromuscular junctions. ␣-syn immunoreactivity also occurred diffusely in regenerating and necrotic muscle fibers. In cultured human muscle fibers, ␣-syn and its mRNA were expressed by immunocytochemistry, immunoblots, and Northern blots. Our study provides the first demonstration that ␣-syn participates in normal and pathologic processes of human muscle. Therefore, its function is not exclusive to the brain and neurodegenerative diseases.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Sporadic inclusion-body myositis (s-IBM), the most common progressive muscle disease in older persons, is of unknown etiology and pathogenesis (reviewed in 1). Light-microscopic features of the s-IBM muscle biopsy include various degrees of mononuclear-cell inflammation, vacuolated muscle fibers (VMFs), congo-red positivity (indicating amyloid) within the VMFs, and 15-21-nm cytoplasmic paired-helical filaments (PHF) <ref type="bibr" target="#b0">(1)</ref>. An intriguing aspect of s-IBM-VMFs is abnormal accumulation of a group of proteins that are accumulated in Alzheimer disease (AD) brain. For example, on a given section, 70%-80% of the VMFs and some of the non-VMFs contain accumulations of amyloid-␤ protein (A␤), C-and N-terminal epitopes of amyloid-␤-precursor protein (A␤PP), apolipoprotein E, presenilin-1, ubiquitin, and other ''Alzheimer-characteristic'' proteins <ref type="bibr" target="#b0">(1)</ref>. A␤PP-mRNA is also increased in inclusion-body myositis (IBM)-VMF <ref type="bibr" target="#b1">(2)</ref>. Like AD brain, IBM muscle PHFs are composed of phosphorylated tau (3), while A␤ is localized to 6-10-nm filaments and floccular and amorphous material <ref type="bibr" target="#b3">(4)</ref>.</p><p>␣ 1 -synuclein is a 140 amino-acid protein whose normal functions are virtually unknown (reviewed in <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref>. Missense mutations in the ␣-synuclein (␣-syn) gene are From the USC Neuromuscular Center, Department of Neurology, University of Southern California Keck School of Medicine, Good Samaritan Hospital, Los Angeles, California.</p><p>Correspondence to: Valerie Askanas, MD, PhD, USC Neuromuscular Center, 637 South Lucas Avenue, Los Angeles, CA <ref type="bibr">90017-1912.</ref> Supported in part by NIH grants (NS 34103 and AG 16768) and by a grant from the Muscular Dystrophy Association (to VA). linked to some forms of familial Parkinson disease (PD) <ref type="bibr" target="#b8">(9)</ref>. ␣-syn is an important component of Lewy bodies in several neurodegenerative diseases <ref type="bibr" target="#b4">(5)</ref><ref type="bibr" target="#b5">(6)</ref><ref type="bibr" target="#b6">(7)</ref><ref type="bibr" target="#b7">(8)</ref><ref type="bibr" target="#b8">(9)</ref><ref type="bibr" target="#b9">(10)</ref><ref type="bibr" target="#b10">(11)</ref><ref type="bibr" target="#b11">(12)</ref><ref type="bibr" target="#b12">(13)</ref> and of glial and neuronal cytoplasmic inclusions in multiple system atrophy <ref type="bibr" target="#b13">(14)</ref><ref type="bibr" target="#b14">(15)</ref><ref type="bibr" target="#b15">(16)</ref>. Recently, ␣-syn immunoreactivity has been shown in axonal swellings in brains of various conditions, including primary and secondary neuroaxonal dystrophy <ref type="bibr" target="#b18">(19)</ref>. The exact role of ␣-syn in AD brain remains uncertain <ref type="bibr" target="#b12">(13,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b19">20)</ref>.</p><p>In this study we examined whether ␣-syn might play a role in the pathogenesis of IBM and in other pathologic and normal processes of human muscle. A, B: in IBM, ␣-syn immunoreactive inclusions co-localize with A␤ inclusions, in the form of small plaquettes and a patchy subplasmalemmal staining. D, E: Small regenerating muscle fibers identified by strong desmin immunoreactivity (E) are strongly immunoreactive for ␣-syn (D). G, H: Necrotic, desmin-negative fiber (H) is strongly ␣-syn immunoreactive (G). Small circular line of immunopositivity (arrows) in both G and H, (yellow in I), possibly indicates an attempt of this fiber to regenerate. Magnification, ϫ900.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients</head><p>We studied diagnostic muscle biopsy specimens (obtained with informed consent) from 30 patients with the following diagnoses: 9 s-IBM, 4 polymyositis, 3 morphologically nonspecific myopathy, 2 myotonic dystrophy, 6 amyotrophic lateral sclerosis, and 6 normal muscle. All diagnoses were based on clinical and laboratory studies, including 18-reaction diagnostic histochemistry of the muscle biopsy specimen <ref type="bibr" target="#b20">(21)</ref>.</p><p>Biopsies of all IBM patients had muscle fibers with vacuoles on Engel-Gomori staining <ref type="bibr" target="#b21">(22)</ref>, 15-to 21-nm PHFs by electronmicroscopy and by SMI-31 immunoreactivity <ref type="bibr" target="#b22">(23)</ref>, and congo-red positivity using fluorescence enhancement <ref type="bibr" target="#b23">(24)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Light-Microscopic Immunocytochemistry</head><p>Immunocytochemical stainings were performed on 10-m transverse sections of fresh-frozen muscle biopsies, using peroxidase-antiperoxidase (PAP) and fluorescence methods as described <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b24">(25)</ref><ref type="bibr" target="#b25">(26)</ref><ref type="bibr" target="#b26">(27)</ref><ref type="bibr" target="#b27">(28)</ref>.</p><p>Two antibodies specifically recognizing ␣-syn were used: mouse monoclonal antibody MAb LB509 (12) (Zymed, San Francisco, CA), diluted 1:50 or 1:100; and rabbit polyclonal antibody directed against amino terminal carboxyl epitope of </p><formula xml:id="formula_0">ϩ ϩ ϩ Ϫ ϩ ϩ ϩ Ϫ Ϫ Ϫ Ϫ ϩ</formula><p>A␤ ϭ amyloid ␤, P-tau ϭ phosphorylated tau.</p><p>␣-syn (16) (Chemicon, Temecula, CA), diluted 1:100. To block nonspecific binding of antibody to Fc receptors, sections were preincubated with 1:10 diluted normal goat serum, as described <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b24">(25)</ref><ref type="bibr" target="#b25">(26)</ref><ref type="bibr" target="#b26">(27)</ref><ref type="bibr" target="#b27">(28)</ref>. Controls for staining specificity were omission of the primary antibody, or its replacement with nonimmune sera or irrelevant antibodies as described <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b24">(25)</ref><ref type="bibr" target="#b25">(26)</ref><ref type="bibr" target="#b26">(27)</ref><ref type="bibr" target="#b27">(28)</ref>. Double immunofluorescence was performed using polyclonal antiserum against ␣-syn combined with either a) mouse monoclonal antibody SMI-31 (Sternberger Monoclonals, Inc., Lutherville, MD), diluted 1:1000, recognizing phosphorylated tau of IBM-PHFs <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b22">23)</ref>, or b) well-characterized monoclonal antibody 6E10 against A␤ (Senetek, Maryland Heights, MO), diluted 1:200, followed by species-specific secondary antibodies labeled either with fluorescence isothiocyanate (FITC) or Texas red, as described <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b24">(25)</ref><ref type="bibr" target="#b25">(26)</ref><ref type="bibr" target="#b26">(27)</ref><ref type="bibr" target="#b27">(28)</ref>. Regenerating and necrotic muscle fibers were identified with either polyclonal or monoclonal antibodies against desmin (Zymed), diluted 1:100, as described ( <ref type="formula">27</ref>), double-labeled with either monoclonal or polyclonal antibody against ␣-syn.</p><p>Neuromuscular junctions were identified by ␣-bungarotoxin binding as described <ref type="bibr" target="#b26">(27,</ref><ref type="bibr" target="#b27">28)</ref> and double-labeled with either monoclonal or polyclonal antibody against ␣-syn.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunoelectronmicroscopy</head><p>This was performed using 10-m unfixed frozen sections adhered to the bottom of 35-mm Petri dishes, as described <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b24">(25)</ref><ref type="bibr" target="#b25">(26)</ref><ref type="bibr" target="#b26">(27)</ref>. In brief, after incubation for 36 h at 4ЊC in a primary antibody, the sections were incubated in either gold-or HRP-conjugated secondary antiserum. Subsequently, the sections were fixed in a 2% paraformaldehyde and 1.2% glutaraldehyde mixture, postfixed in osmium, and embedded in Epon in situ in the Petri dish <ref type="bibr" target="#b28">(29)</ref>. The embedded section in the dish was viewed under phase-contrast microscopy and compared with an adjacent cross-section that had been incubated with the same antibody as for immunoelectronmicroscopy but stained with the PAP reaction. The identical VMFs that contained PAPpositive inclusions were identified in the adjacent gold-labeled Epon-embedded section, were marked, and 1-mm diameter cores were drilled out <ref type="bibr" target="#b28">(29)</ref>. From the cores, each containing at least 1 vacuolated muscle fiber, thin sections were cut, counterstained with uranyl acetate and lead citrate, and examined by electronmicroscopy.</p><p>For ultrastructural double immunolocalization, the method was essentially the same, except that sections were incubated simultaneously in 2 antibodies directed against different antigens and raised in different species. This was followed by incubation in 2 correspondingly appropriate secondary antibodies, 1 labeled with 5-nm gold and the other with 15-or 10-nm gold as described (4).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cultured Human Muscle Fibers</head><p>Tissue cultures of normal human muscle were established as previously described, from satellite cells of portions of diagnostic muscle biopsies from patients who, after all tests were performed, were considered free of muscle disease (reviewed in 30). Cultures were maintained in F14 medium (Gibco), supplemented with 10% fetal bovine serum (HyClone), insulin (10 ug/ml, Sigma), and an antibiotic/antimycotic mixture (Sigma) <ref type="bibr" target="#b29">(30)</ref>. This medium promotes differentiation of aneurally cultured human muscle and enables its maintenance for several weeks <ref type="bibr" target="#b29">(30)</ref>. Three-week-old cultures were processed for immunoblots, Northern blots, immunocytochemistry, and in situ hybridization as described <ref type="bibr" target="#b30">(31)</ref><ref type="bibr" target="#b31">(32)</ref>. ␣-syn MAb LB509 antibody was used for both immunocytochemistry and immunoblots. For Northern blots we used a cRNA probe transcribed from a cDNA template spanning from the 5Ј untranslated region (UTR) to a Bam HI site at position 406 of the ␣-syn cDNA (gene bank access #L08850). cDNA was cloned into a pGEM-4Z vector (Promega, Madison, WI).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Light Microscopic Immunocytochemistry</head><p>IBM: Approximately 50% of IBM-VMFs in all IBM muscle biopsies contained small strongly immunoreactive ␣-syn inclusions located internally in the fibers (Figs. <ref type="figure" target="#fig_0">1,  2</ref>). Some VMFs had also patchy subplasmalemmal staining and a slight diffuse cytoplasmic immunoreactivity. On sections double-immunostained for both A␤ and ␣syn, ␣-syn co-localized with A␤ (Fig. <ref type="figure" target="#fig_0">2B</ref>). However, only 60%-70% of A␤-positive muscle fibers had ␣-syn immunoreactive inclusions.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gold Immunoelectronmicroscopy</head><p>Results summarized in the Table <ref type="table">.</ref> Within IBM-abnormal muscle fibers ␣-syn immunoreactivity was localized to 6-to 10-nm-diameter amyloid-like fibrils, and amorphous and floccular material (Fig. <ref type="figure">3</ref>). On those structures, ␣-syn was close to A␤ (Fig. <ref type="figure">3</ref>). ␣-syn was not localized on the 15-21-nm PHFs (Fig. <ref type="figure">4</ref>). While PHFs were strongly labeled with antibodies recognizing phosphorylated tau, ␣-syn was located on the 6-10-nm amyloidlike fibrils and/or amorphous material close to the PHFs, but was not on the PHFs themselves (Fig. <ref type="figure">4</ref>). There was no ␣-syn immunoreactivity associated with normal myofibrils, nor on the myelin-like whorls, various lysosomal inclusions, and lipofuscin granules typically present in IBM vacuolated muscle fibers.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Other Diseased and Normal Muscle</head><p>None of the normal muscle biopsies had ␣-syn immunoreactive inclusions that were characteristic of IBM abnormal muscle fibers. Regenerating muscle fibers, Fig. <ref type="figure">3</ref>. Gold immunoelectronmicroscopy of IBM abnormal muscle fibers. A, B: Single labeling of ␣-syn. Gold particles (10nm) label 6-10-nm filaments and amorphous material. Adjacent portions of the myofiber (asterisk) (B) are not immunolabeled. C-F: Double immunolabeling of ␣-syn (5-nm gold particles) and A␤ (C, F, 10-nm gold particles; D-E, 15-nm gold particles). ␣syn and A␤ immunodecorate 6-10-nm filaments and amorphous inclusions. On those structures, A␤ is close to ␣-syn. Magnifications: A, ϫ53,000; B, ϫ42,600; C, ϫ32,000; D, ϫ30,000; E, ϫ42,660; F, ϫ85,000.</p><p>identified by positive desmin immunoreactivity, in all biopsies that contained them, had diffusely increased cytoplasmic ␣-syn immunoreactivity (Fig. <ref type="figure" target="#fig_0">2D-F</ref>). Very strong ␣-syn immunopositivity was also present in necrotic muscle fibers, identified by lack of desmin immunoreactivity (27) (Fig. <ref type="figure" target="#fig_0">2G-I</ref>). In all biopsies, there was strong ␣-syn immunoreactivity at the postsynaptic domain of the neuromuscular junctions, which closely colocalized with ␣-bungarotoxin bound to the nicotinic acetylcholine receptors (Fig. <ref type="figure">5</ref>). When the primary antibody was omitted or replaced by either a nonimmune serum or an irrelevant antibody, the immunoreaction did not take place.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cultured Human Muscle Fibers</head><p>Three-week-old cultured muscle fibers had a) strong ␣syn immunoreactivity; b) an 18-kDa ␣-syn band on immunoblots; and c) a 1.5-Kb ␣-syn band on Northern blots (Fig. <ref type="figure" target="#fig_2">6</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>In 1993, a 140 amino acid protein was isolated from AD amyloid plaques and named ''NAC'' (non-A␤ component of AD amyloid) <ref type="bibr" target="#b16">(17)</ref>. The cloned DNA encoding NAC precursor was named ''NACP'' <ref type="bibr" target="#b16">(17)</ref>. NAC localized to the 6-10-nm amyloid fibrils in AD brain and has been shown to have strong tendency to form ␤-structures <ref type="bibr" target="#b16">(17)</ref>. NACP was detected as 19-kD protein in the cytosolic component of brain homogenates <ref type="bibr" target="#b16">(17)</ref>. Its mRNA was strongly expressed in brain, and in low concentrations in other tissues, but not in liver <ref type="bibr" target="#b16">(17)</ref>. In 1994, Jake et al <ref type="bibr" target="#b32">(33)</ref> cloned from human brain 2 proteins, 1 identical to human NACP and the other to rat synuclein; they named them ␣and ␤-synuclein, respectively. Synelphin, cloned from zebra finch brain by George et al, in 1995 <ref type="bibr" target="#b33">(34)</ref>, is now known to be a homologue of ␣-synuclein. ␤-synuclein and ␥-synuclein are 2 other proteins of the synuclein family (reviewed in 5-8). Normal biological functions of the synucleins are relatively unknown.</p><p>␣-synuclein, but not ␤-synuclein, plays an important role in neurodegenerative diseases of the brain. Missense mutations in the ␣-syn gene cause some forms of hereditary PD <ref type="bibr" target="#b8">(9)</ref>, and ␣-syn is a major component of abnormal brain structures in various neurodegenerative disorders (reviewed in 5-9).</p><p>Our data suggest that ␣-syn plays a role in pathologic and normal processes of human muscle. In s-IBM, immunolocalization of ␣-syn in VMFs was similar to that described in AD brain; ␣-syn was localized to amyloidlike fibrils, where it co-localized with A␤, and it was not present on the phosphorylated-tau containing paired-helical filaments <ref type="bibr" target="#b12">(13)</ref>. As in the brain of various neurodegenerative disorders, the mechanism and the initiating event and pathogenic steps leading to accumulation of ␣-syn in IBM muscle fibers are not yet known. We have previously demonstrated that accumulation of A␤PP epitopes precedes other abnormalities in IBM muscle fibers <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b31">32)</ref>. In the present study, only 60%-70% of the A␤-containing muscle fibers had ␣-syn immunoreactivity, suggesting that accumulation of A␤ may precede ␣-syn deposition. It was previously demonstrated that ␣-syn associates with A␤ containing amyloid fibrils in AD brain <ref type="bibr" target="#b16">(17)</ref>, and that in vitro ␣-syn a) binds to pre-existing A␤ <ref type="bibr" target="#b34">(35,</ref><ref type="bibr" target="#b35">36)</ref> and b) stimulates A␤ aggregation <ref type="bibr" target="#b36">(37)</ref>. In vitro, ␣-syn is prone to self-aggregation and can form amyloid fibrils <ref type="bibr" target="#b37">(38)</ref><ref type="bibr" target="#b38">(39)</ref><ref type="bibr" target="#b39">(40)</ref><ref type="bibr" target="#b40">(41)</ref>. Accordingly, one can speculate that in IBM muscle fibers a) ␣-syn binds to previously accumulated A␤; b) some of the congophilic inclusions are composed of both A␤ and ␣-syn, and c) binding of ␣-syn to A␤ and vice-versa, might accelerate and increase their fibrillogenesis there.</p><p>In vitro, oxidative stress has been shown to induce aggregation of ␣-syn into amyloid-like fibrils <ref type="bibr" target="#b41">(42)</ref>. Since oxidative stress seems to play a role in IBM pathogenesis <ref type="bibr" target="#b42">(43)</ref>, this mechanism may contribute to post-translational modification of ␣-syn and its aggregation in IBM.</p><p>Even though ␣-syn is traditionally considered a presynaptic protein, this designation appears too narrow. The previous identification of ␣-syn in glial cytoplasmic inclusions in multiple system atrophy, the presence of ␣syn in megakaryocytes <ref type="bibr" target="#b43">(44)</ref>, and our demonstration of ␣syn in IBM abnormal muscle fibers indicates its presence and probable role in various cell types. Our finding of increased ␣-syn immunoreactivity in human regenerating and necrotic muscle fibers and the presence of ␣-syn and its mRNA in cultured human muscle fibers points to its possible role both in human muscle development and necrotic muscle cell death. Moreover, ␣-syn immunoreactivity at the postsynaptic domain of human nerve-muscle junctions, both by light microscopy (this paper), and by immunoelectronmicrosocpy (Askanas and Alvarez, unpublished observation) suggest that ␣-syn may play a role in postsynaptic nerve-muscle communication, such as in signaling and/or maintaining the nerve-muscle junction. It is also possible that at the nerve-muscle junction ␣-syn is at least partially bound to A␤, since all A␤PP epitopes, including A␤ <ref type="bibr" target="#b27">(28)</ref>, and A␤PP-mRNA (2) are normally accumulated there.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSION</head><p>Our studies demonstrate that abnormal accumulation of ␣-syn occurs in diseased human muscle and thus is not unique to the brain disorders. Since ␣-syn is synthesized by human muscle in culture, normal and pathologic cultured human muscle models, such as, a) normal cultured muscle after A␤PP gene transfer <ref type="bibr" target="#b30">(31,</ref><ref type="bibr" target="#b31">32)</ref>, and b) cultured genetically-abnormal muscle from hereditary inclusion-body myopathy <ref type="bibr" target="#b44">(45)</ref> should provide living human model of the tissue affected by ␣-syn accumulation in vivo and more readily available than brain, for a wide range of molecular studies of ␣-syn transcription, translation, and processing. Such studies might contribute to a better understanding of functions of ␣-syn in normal and abnormal human muscle, and perhaps be relevant to neurodegenerative diseases.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 2 .</head><label>2</label><figDesc>Fig 2. Double immunofluorescence labeling of ␣-syn (A, D, G) with A␤ (B) and desmin (E, H). C, F, I: Double exposure.A, B: in IBM, ␣-syn immunoreactive inclusions co-localize with A␤ inclusions, in the form of small plaquettes and a patchy subplasmalemmal staining. D, E: Small regenerating muscle fibers identified by strong desmin immunoreactivity (E) are strongly immunoreactive for ␣-syn (D). G, H: Necrotic, desmin-negative fiber (H) is strongly ␣-syn immunoreactive (G). Small circular line of immunopositivity (arrows) in both G and H, (yellow in I), possibly indicates an attempt of this fiber to regenerate. Magnification, ϫ900.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 4 .Fig. 5 .</head><label>45</label><figDesc>Fig. 4. Gold immunoelectronmicroscopy of IBM abnormal muscle fibers. A-C: Double immunolabeling of ␣-syn (10-nm gold) and SMI-31 (5-nm gold). SMI-31 antibody, which recognizes phosphorylated tau on IBM-PHFs<ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b22">23)</ref>, labels the PHFs. The ␣-syn label is on structures close to PHFs but is not on the PHFs. Magnification, ϫ100,000</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 6 .</head><label>6</label><figDesc>Fig. 6. Expression of ␣-syn in 3-week-old cultures of adult normal human muscle. A: PAP immunostaining. ␣-syn is strongly localized in the cytoplasm of cultured muscle fibers, while nuclei are not stained. ϫ 600. B: Autoradiogram of Northern blots showing a 1.5-kb band corresponding to ␣-syn. C: Immunoblot showing 18-kDa band corresponding to ␣-syn.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE Subcellular</head><label>Subcellular</label><figDesc></figDesc><table><row><cell cols="4">Localization of ␣-Synuclein, A␤, and</cell></row><row><cell cols="4">Phosphorylated Tau in Inclusion-Body Myositis Muscle</cell></row><row><cell>Structure</cell><cell>␣-synuclein</cell><cell>A␤</cell><cell>P-tau</cell></row><row><cell>6-10-nm amyloid-like fibrils</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Amorphous structures</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Floccular material</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Paired-helical filaments</cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0">Downloaded from https://academic.oup.com/jnen/article/59/7/592/2609907 by University of Illinois Law Library user on 08 March 2023</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1">J Neuropathol Exp Neurol, Vol 59, July, 2000</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p>The ␣-synuclein cDNA was generously provided by Dr. Virginia Lee. Maggie Baburyan provided excellent assistance in photography and electronmicroscopy.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Rheumatol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="389" to="405" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">␤-amyloid precursor protein mRNA is increased in inclusion-body myositis muscle</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="815" to="818" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="774" to="786" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Light-and electronmicroscopic localization of ␤-amyloid protein in muscle biopsies of patients with inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Alpha-synuclein and the Lewy body</title>
		<author>
			<persName><forename type="first">M</forename><surname>Goedert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Spillantini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci News</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="47" to="52" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Clayton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>George</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Neurosci</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="249" to="254" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The synuclein family</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lavedan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="871" to="880" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Filamentous nerve cell inclusions in neurodegenerative diseases</title>
		<author>
			<persName><forename type="first">M</forename><surname>Goedert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Spillantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Davies</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Neurobiol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="619" to="632" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The genetics of disorders with synuclein pathology and parkinsonism</title>
		<author>
			<persName><forename type="first">M</forename><surname>Farrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gwinn-Hardy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hutton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hardy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1901" to="1905" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">␣-synuclein in Lewy bodies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Spillantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vm-Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Q</forename><surname>Trojanowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goedert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">388</biblScope>
			<biblScope unit="page" from="839" to="840" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">␣-synuclein in filamentous inclusions of Lewy bodies from Parkinson&apos;s disease and dementia with Lewy bodies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Spillantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Crowther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goedert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="6469" to="6473" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Lewy bodies contain altered ␣-synuclein in brains of many familial Alzheimer&apos;s disease patients with mutations in presenilin and amyloid precursor protein genes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Lippa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fujiwara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dma</forename><surname>Mann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1365" to="1370" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Abnormal accumulation of NACP/␣-synuclein in neurodegenerative disorders</title>
		<author>
			<persName><forename type="first">A</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mallory</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sundsmo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Honer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Masliah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="367" to="372" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble ␣-synuclein</title>
		<author>
			<persName><forename type="first">P-H</forename><surname>Tu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Galvin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baba</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="415" to="422" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">␣-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Wakabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yoshimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tsuji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takahashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">249</biblScope>
			<biblScope unit="page" from="180" to="182" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Multiple-system atrophy: A new alpha-synuclein disease?</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Gai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Power</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Blumbergs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Blessing</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">352</biblScope>
			<biblScope unit="page" from="547" to="548" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ue ´da</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fukushima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Masliah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="11282" to="11286" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">E</forename><surname>Masliah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iwai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mallory</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ue ´da</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Saitoh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="201" to="210" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">␣-synuclein immunoreactivity is present in axonal swelling in neuroaxonal dystrophy and acute traumatic brain injury</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Newell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Boyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gomez-Tortosa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="1263" to="1268" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Non-A␤ component of Alzheimer&apos;s disease amyloid (NAC) revisited. NAC and ␣-synuclein are not associated with A␤ amyloid</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Culvenor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Mclean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cutt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="1173" to="1181" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Muscle biopsies in neuromuscular diseases</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Clin N Am</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="963" to="995" />
			<date type="published" when="1967">1967</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Rapid examination of muscle tissuean improved trichrome method for fresh-frozen biopsy sections</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Cunningham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="919" to="923" />
			<date type="published" when="1963">1963</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Use of antineurofilament antibody to identify paired-helical filaments in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="389" to="391" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Enhanced detection of Congored-positive amyloid deposits in muscle fibers of inclusion-body myositis and brain of Alzheimer disease using fluorescence technique</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1265" to="1267" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Light and electron microscopic immunolocalization of Presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vm-Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wisniewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="889" to="895" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Nitricoxide induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="1089" to="1097" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Immunolocalization of transcription factor NF-B in inclusion-body myositis muscle and at normal human neuromuscular junctions</title>
		<author>
			<persName><forename type="first">C-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">254</biblScope>
			<biblScope unit="page" from="77" to="80" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Strong immunoreactivity of ␤-amyloid precursor protein, including the ␤-amyloid protein sequence, at human neuromuscular junctions</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="96" to="100" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">A technique of fiber selection from human muscle tissue cultures for histochemical-electronmicroscopic studies</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Histochem Cytochem</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="144" to="146" />
			<date type="published" when="1975">1975</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main">Cultured normal and genetically abnormal human muscle</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<editor>Rowland LP, DiMauro S</editor>
		<imprint>
			<date type="published" when="1992">1992</date>
			<publisher>North Holland</publisher>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="85" to="116" />
			<pubPlace>Amsterdam</pubPlace>
		</imprint>
	</monogr>
	<note>The handbook of clinical neurology, myopathies</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Transfer of ␤-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">´s</forename><surname>Baque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1314" to="1319" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">␤APP gene transfer into cultured human muscle induces inclusion-body myositis aspects</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">´s</forename><surname>Baque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2155" to="2158" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Identification of two distinct synucleins from human brain</title>
		<author>
			<persName><forename type="first">R</forename><surname>Jakes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Spillantini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goedert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">345</biblScope>
			<biblScope unit="page" from="27" to="32" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Characterization of a novel protein regulated during the critical period for song learning in the zebra finch</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Woods</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Clayton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="361" to="372" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Residues in the synuclein consensus motif of the ␣-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid ␤A4 peptide</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Sørensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gliemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Rasmussen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="91" to="94" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Binding of A␤ to ␣-and ␤-synucleins: Identification of segments in ␣-synuclein/NAC precursor that bind A␤ and NAC</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Højrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hager</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="539" to="546" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">NACP, the precursor of non-amyloid ␤/A4 protein (A␤) component of Alzheimer disease amyloid, binds A␤ and stimulates A␤ aggregation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yoshimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Iwai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dac</forename><surname>Otero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Saitoh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="9141" to="9145" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Non-A␤ component of Alzheimer&apos;s disease amyloid (NAC) is amyloidogenic</title>
		<author>
			<persName><forename type="first">A</forename><surname>Iwai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yoshimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Masliah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Saitoh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="10139" to="10145" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Human recombinant NACP/ ␣-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sisk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">799</biblScope>
			<biblScope unit="page" from="301" to="306" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">The core Alzheimer&apos;s peptide NAC forms amyloid fibrils which seed and are seeded by ␤-amyloid: Is NAC a common trigger or target in neurodegenerative disease?</title>
		<author>
			<persName><forename type="first">H</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Weinreb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Lansbury</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem Biol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="163" to="169" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Comparisons of the NACP self-oligomerizations induced by A␤25-35 in the presence of dicyclohexylcarbodiimide and N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline</title>
		<author>
			<persName><forename type="first">J-H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-J</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Paik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurochem Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1427" to="1434" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="717" to="721" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Diseases of oxidative stress and aging?</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="915" to="920" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">NACP, a synaptic protein involved in Alzheimer&apos;s disease, is differentially regulated during megakaryocyte differentiation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yoshimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sisk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Comm</title>
		<imprint>
			<biblScope unit="volume">237</biblScope>
			<biblScope unit="page" from="611" to="616" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Impaired innervation of cultured human muscle overexpressing ␤APP experimentally and genetically: Relevance to inclusion-body myopathies</title>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="3201" to="3205" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
